Similar articles

• Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk.

  Economopoulos KP, Sergentanis TN. Economopoulos KP, et al. Int J Cancer. 2010 May 15;126(10):2509. doi: 10.1002/ijc.24876. Int J Cancer. 2010. PMID: 19739120 No abstract available.
• Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study.

  He XF, Su J, Zhang Y, Huang X, Liu Y, Ding DP, Wang W, Arparkorn K. He XF, et al. Breast Cancer Res Treat. 2011 Nov;130(2):517-29. doi: 10.1007/s10549-011-1583-2. Epub 2011 May 22. Breast Cancer Res Treat. 2011. PMID: 21604156
• Need for clarification of data in a recent meta-analysis about TP53 codon 72 polymorphism and cancer susceptibility.

  Lu PH, Wei MX, Li C, Shen W, Chen MB. Lu PH, et al. Carcinogenesis. 2011 Mar;32(3):443; author reply 444. doi: 10.1093/carcin/bgq261. Epub 2010 Dec 6. Carcinogenesis. 2011. PMID: 21135152 No abstract available.
• Evidence against involvement of p53 polymorphism in breast cancer predisposition.

  Suspitsin EN, Buslov KG, Grigoriev MY, Ishutkina JG, Ulibina JM, Gorodinskaya VM, Pozharisski KM, Berstein LM, Hanson KP, Togo AV, Imyanitov EN. Suspitsin EN, et al. Int J Cancer. 2003 Jan 20;103(3):431-3. doi: 10.1002/ijc.10834. Int J Cancer. 2003. PMID: 12471629 Review. No abstract available.
• Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?

  Sousa H, Santos AM, Pinto D, Medeiros R. Sousa H, et al. Acta Med Port. 2011 Jan-Feb;24(1):127-34. Epub 2011 Feb 28. Acta Med Port. 2011. PMID: 21672450 Review.